NEUWAY Pharma's Series A - II Round

NEUWAY Pharma raised a round of funding on October 29, 2015.

NEUWAY Pharma is focusing on the preclinical and clinical development of innovative therapeutics for treatment of orphan brain diseases based on its proprietary Central Nervous System (CNS) drug deliv…

Articles about NEUWAY Pharma's Series A - II Round: